XOMA Royalty Corp. (XOMA) Balance Sheet

The stabilization of total assets indicates that the company is effectively managing its portfolio turnover without eroding its underlying capital base. Investors should monitor whether this trajectory continues to favor asset accumulation over cash depletion as the company navigates the inherent volatility of its milestone-heavy revenue model.

The current leverage profile appears strategic rather than necessity-driven, allowing the firm to maintain liquidity for opportunistic asset purchases. However, the reliance on debt to finance the portfolio requires consistent royalty inflows to ensure that refinancing risks remain contained in a higher-rate environment.

This liquidity cushion is essential for a business model that relies on the timing of partner-led regulatory milestones, which are notoriously difficult to forecast. The current cash position suggests the company is well-positioned to weather short-term operational volatility without needing to access dilutive capital markets.

The shift toward higher intangible asset values warrants close scrutiny, as these assets are subject to impairment risks if the underlying clinical programs fail to meet development milestones. The minimal PPE footprint confirms the company's asset-light model, shifting the primary risk from physical capital to the valuation of intellectual property.